The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 18 06 2019
revised: 15 10 2019
accepted: 17 10 2019
pubmed: 5 11 2019
medline: 30 1 2021
entrez: 4 11 2019
Statut: ppublish

Résumé

To evaluate the effect of an antimicrobial stewardship programme in two intensive care units (ICUs) of a teaching hospital. Between January 2017 and June 2018 we conducted a prospective, interventional, interrupted time-series study, based on Prospective Audit and Feedback in two ICUs of an acute-care teaching hospital. The primary outcomes were the difference in the antibiotic consumption, and the incidence of bloodstream infections (BSI) caused by multidrug-resistant (MDR) organisms. The secondary outcomes included the hospital mortality rate, the mean length of stay and the antibiotic expense. During the study, 231 audits were performed, evaluating 693 antibiotic prescriptions. The programme led to a global reduction in antibiotic consumption, with a change in level (CL) of -324.8 defined daily doses (DDD)/100 patient-days (PD), p 0.04, and particularly in the use of fluoroquinolone: (CL: -63.48 DDD/100 PD, p < 0.001). A non-significant reduction was obtained for the consumption of carbapenems (CL: -34.7 DDD/100 PD, p 0.25) and third- and fourth-generation cephalosporins (CL: -27.3 DDD/100 PD, p 0.102). Furthermore, we registered a significant decrease in all BSI (CL: -5.8 events/100 PD, p 0.026) and in BSI due to MDR Gram-negative organisms (CL: -2.96 events/100 PD, p 0.043). No difference was observed in the hospital mortality and length of stay. Our study demonstrated that implementation of an antimicrobial stewardship programme in two ICUs of a teaching hospital induced a significant reduction in antibiotic consumption and in the incidence of BSI due to MDR Gram-negative organisms, without any impact on the mortality rate.

Identifiants

pubmed: 31678230
pii: S1198-743X(19)30557-9
doi: 10.1016/j.cmi.2019.10.021
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

782.e1-782.e6

Informations de copyright

Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

L Onorato (L)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy; Infectious Diseases Unit, AORN, Caserta, Italy.

M Macera (M)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy.

F Calò (F)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy.

C Monari (C)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy.

F Russo (F)

Direzione Sanitaria, AOU Vanvitelli, Naples, Italy.

M R Iovene (MR)

Microbiology Unit, AOU Vanvitelli, Naples, Italy.

G Signoriello (G)

Department of Mental Health and Public Medicine-Medical Statistics Unit, University of Campania Luigi Vanvitelli, Italy.

R Annibale (R)

Pharmacy Unit, AOU Vanvitelli, Naples, Italy.

M C Pace (MC)

Intensive Care, Department of Child, University of Campania, Luigi Vanvitelli, Naples, Italy.

C Aurilio (C)

Intensive Care Unit, AOU Vanvitelli, Naples, Italy.

G B Gaeta (GB)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy.

N Coppola (N)

Department of Mental Health and Public Medicine-Infectious Diseases Unit, University of Campania Luigi Vanvitelli, Italy; Infectious Diseases Unit, AORN, Caserta, Italy. Electronic address: nicola.coppola@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH